Tag: Arbutus Biopharma

December 8, 2019

5 Top NASDAQ Biotech and Pharma Stocks: Atreca Climbs 45 Percent

Which biotech and pharma stocks were on the rise last week? We list the top gainers and what may have...
November 3, 2019

5 Top NASDAQ Biotech and Pharma Stocks: IVERIC Up 350 Percent

Which biotech and pharma stocks were on the rise last week? We list the top gainers and what may have...
June 23, 2019

5 Top Weekly NASDAQ Biotech and Pharma Stocks: Melinta Leads

Which companies were last week's top gainers? We break down the five top NASDAQ biotech and pharma stocks of the...
June 20, 2019

Arbutus Biopharma Gets Green Light for Phase 1a/1b Clinical Trial

Shares of the company spiked nearly 40 percent following the announcement it can begin its Phase 1a/1b clinical trial of...
September 9, 2018

5 Top Weekly NASDAQ Biotech Stocks: MannKind Soars 83 Percent

MannKind, Evofem Biosciences, Arbutus Biopharma, Infinity Pharmaceuticals and VBI Vaccines were last week's top gainers on the NASDAQ Biotechnology Index.
August 13, 2018

Alnylam Pharma Receives FDA Approval for Onpattro

On Friday, Alnylam Pharmaceuticals received US Food and Drug Administration approval for Onpattro (patisiran).
August 13, 2018

Arbutus’ LNP Licensee Alnylam Announces FDA Approval of ONPATTRO (patisiran), for the Treatment of ATTR Amyloidosis

Arbutus Biopharma (Nasdaq:ABUS), an industry-leading Hepatitis B Virus (HBV) therapeutic solutions company, today announced that the Company’s lipid nanoparticle (LNP)...